Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin 0.5% eye drops in acute bacterial conjunctivitis
2012-003664-41Phase 4Completed
- Sponsor
- Antibiotic-Razgrad
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of levofloxacin in bacterial conjunctivitis (BC) (2 arms), sponsored by Antibiotic-Razgrad. Primary endpoints: Microbiological eradication rate and Biomicroscopy findings. Started Jan 2013; status: completed.
02
Drugs
levofloxacin
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on 2012-003664-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003664-41.